Association of Antibodies to Prevotella copri in Anti–Cyclic Citrullinated Peptide‐Positive Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis
Arthritis & Rheumatology · 2023-04 · 75 (4) · 507-516
DOI: 10.1002/art.42370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 22.02.2023. Verfasst von Jennifer A Seifert und 17 weiteren Autor:innen. Beteiligte Einrichtung: University of Colorado Denver. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIAMS NIH HHS, NIH.
Abstract (Originalsprache)
Objective
Prevotella copri ( P copri ), a gut commensal, has been reported to be an immune‐relevant organism in individuals with rheumatoid arthritis (RA). This study sought to evaluate anti– P copri (anti– Pc ) antibody responses in our participant cohorts and to determine when in the natural history of RA such responses develop.
Methods
We analyzed serum levels of immunoglobulin A (IgA) and IgG antibodies from a 27‐kd protein of P copri (anti– Pc ‐ p27), an immunogenic P copri protein, in study participants at risk of developing RA, participants who transitioned to RA, participants with early RA (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Colorado Denver.
- Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
- Benaroya Research Institute at Virginia Mason, Seattle, Washington.
- Feinstein Institutes for Medical Research and North Shore-Long Island Jewish Health System, Manhasset, New York.
- University of Chicago, Illinois.
- University of Nebraska Medical Center and VA Nebraska-Western Iowa Healthcare System, Omaha, Nebraska.
ORCID-Profile: Jennifer A Seifert, Chelsie Fleischer, M Kristen Demoruelle, Ted R Mikuls, Kevin D Deane, Allen C Steere
Förderung
- NIAID NIH HHS
- NIAMS NIH HHS
- NIH
- Mathers Foundation
- Lucius N. Littauer Foundation
Zitieren
APA
Seifert, J. A., Bemis, E. A., Ramsden, K., Lowell, C., Polinski, K., Feser, M., Fleischer, C., Demoruelle, M. K., Buckner, J., Gregersen, P. K., Keating, R. M., Mikuls, T. R., O'Dell, J. R., Weisman, M. H., Deane, K. D., Norris, J. M., Steere, A. C., & Holers, V. M. (2023). Association of Antibodies to Prevotella copri in Anti–Cyclic Citrullinated Peptide‐Positive Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis. Arthritis & Rheumatology, 75(4), 507-516. https://doi.org/10.1002/art.42370
Vancouver
Seifert JA, Bemis EA, Ramsden K, Lowell C, Polinski K, Feser M, et al. Association of Antibodies to Prevotella copri in Anti–Cyclic Citrullinated Peptide‐Positive Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis. Arthritis & Rheumatology. 2023;75(4):507-516. doi:10.1002/art.42370
BibTeX
@article{Seifert2023,
author = {Seifert, Jennifer A and Bemis, Elizabeth A and Ramsden, Kristina and Lowell, Cassidy and Polinski, Kristen and Feser, Marie and Fleischer, Chelsie and Demoruelle, M Kristen and Buckner, Jane and Gregersen, Peter K and Keating, Richard M and Mikuls, Ted R and O'Dell, James R and Weisman, Michael H and Deane, Kevin D and Norris, Jill M and Steere, Allen C and Holers, V Michael},
title = {Association of Antibodies to Prevotella copri in Anti–Cyclic Citrullinated Peptide‐Positive Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis},
journal = {Arthritis & Rheumatology},
year = {2023},
volume = {75},
number = {4},
pages = {507--516},
doi = {10.1002/art.42370}
}
EUVIMED